Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from ...

Bank of America upgraded shares of Henry Schein (NASDAQ:HSIC – Free Report) from an underperform rating to a buy rating in a research report sent to investors on Monday, MarketBeat.com reports. Bank ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

As previously reported, BofA analyst Allen Lutz upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69, ...

BofA upgraded Henry Schein (HSIC) to Buy from Underperform with an $84 price target Don't Miss Our New Year's Offers:Discover the latest stocks ...

HSIC currently has a market capitalization of $9.19 billion. Estimates for 2024 earnings have moved north 0.6% to $4.77 in the past 30 days. Its earnings surpassed estimates in three of the ...

Henry Schein Inc. closed $14.08 below its 52-week high ($82.63), which the company achieved on February 27th.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Below is Validea's guru fundamental report for HENRY SCHEIN, INC. (HSIC). Of the 22 guru strategies we follow, HSIC rates highest using our Shareholder Yield Investor model based on the published ...

Below is Validea's guru fundamental report for HENRY SCHEIN, INC. (HSIC). Of the 22 guru strategies we follow, HSIC rates highest using our Shareholder Yield Investor model based on the published ...